Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
Alice Welbourn: WHO and the rights of women living with HIV

A recent set of articles on HIV in pregnancy, published by The BMJ and BMJ Open, raises concerns that some combination anti-retroviral therapies (cARTs) may harm babies. This highlights the need for changes to current WHO practice towards pregnant women living with HIV, which is no doubt well-intentioned but ill thought-out.

Published
12 September 2017
From
BMJ Opinion
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
25 July 2017
By
Carole Leach-Lemens
I'm A Grandmother, I Have HIV, And I Can't Pass It On

This is one of the biggest developments since the start of the HIV epidemic, yet people don’t know it. It means people can have sex, relationships and children, with someone living with HIV, without becoming infected. For some it can sound a bit unreal - but it’s true. And if everyone know this we could stop HIV stigma.

Published
19 July 2017
From
HuffPost UK
Why are women lost from HIV care during pregnancy? Malawi study shows social support and counselling are critical

Lack of social support after diagnosis and inadequate counselling about HIV treatment and HIV disclosure were identified as key reasons for dropping out of HIV

Published
28 June 2017
By
Keith Alcorn
Meds May Impact Prenatal Screening in HIV+ Patients

Pregnant women with HIV taking integrase inhibitors at the time of their non-invasive prenatal screening test had a lower mean fetal fraction than those who were not taking the medication, a small study found here.

Published
08 June 2017
From
MedPage Today HIV/AIDS
Combining drug addiction treatment and perinatal HIV prevention leads to good outcomes in Kenya

An integrated programme offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according

Published
18 May 2017
By
Liz Highleyman
Early ART highly acceptable and achieves excellent rates of viral suppression among young South African women

Early antiretroviral therapy (ART) is highly acceptable to the majority of young women with HIV in South Africa, according to research published in AIDS and Behavior.

Published
27 April 2017
By
Michael Carter
The living legacy of the Global Plan: eliminating HIV in children

The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

Published
20 April 2017
From
UNAIDS
Dolutegravir regimen highly effective in clinical trial for women

A once-daily regimen containing the potent HIV integrase inhibitor dolutegravir worked better than an older atazanavir-containing regimen – with higher rates of viral suppression both overall and across

Published
07 November 2016
By
Liz Highleyman
Early HIV treatment: mothers say they need time to think

Findings from the first randomised controlled trial to date evaluating postpartum antiretroviral therapy (ART) for women with high CD4 cell counts (over 400 cells/mm3) highlight a critical need

Published
26 July 2016
By
Carole Leach-Lemens

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.